CN106387795A - 一种玉竹桑叶蜂王浆含片及生产方法 - Google Patents
一种玉竹桑叶蜂王浆含片及生产方法 Download PDFInfo
- Publication number
- CN106387795A CN106387795A CN201610747300.5A CN201610747300A CN106387795A CN 106387795 A CN106387795 A CN 106387795A CN 201610747300 A CN201610747300 A CN 201610747300A CN 106387795 A CN106387795 A CN 106387795A
- Authority
- CN
- China
- Prior art keywords
- rhizoma polygonati
- polygonati odorati
- royal jelly
- folium mori
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 229940109850 royal jelly Drugs 0.000 title claims abstract description 36
- 238000004519 manufacturing process Methods 0.000 title claims description 14
- 235000008708 Morus alba Nutrition 0.000 title abstract 11
- 240000000249 Morus alba Species 0.000 title abstract 11
- 239000006189 buccal tablet Substances 0.000 title abstract 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 38
- 239000000843 powder Substances 0.000 claims abstract description 7
- 239000002994 raw material Substances 0.000 claims abstract description 7
- 239000008176 lyophilized powder Substances 0.000 claims description 32
- 239000007937 lozenge Substances 0.000 claims description 24
- 238000000034 method Methods 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 7
- 238000003809 water extraction Methods 0.000 claims description 7
- 239000012535 impurity Substances 0.000 claims description 6
- 239000006228 supernatant Substances 0.000 claims description 6
- 238000009835 boiling Methods 0.000 claims description 4
- 238000005119 centrifugation Methods 0.000 claims description 4
- 238000004108 freeze drying Methods 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- SRBFZHDQGSBBOR-IOVATXLUSA-N Xylose Natural products O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 claims description 3
- 239000008213 purified water Substances 0.000 claims description 3
- 239000003826 tablet Substances 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 claims description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 claims description 2
- 239000003752 hydrotrope Substances 0.000 claims description 2
- QUCDWLYKDRVKMI-UHFFFAOYSA-M sodium;3,4-dimethylbenzenesulfonate Chemical compound [Na+].CC1=CC=C(S([O-])(=O)=O)C=C1C QUCDWLYKDRVKMI-UHFFFAOYSA-M 0.000 claims description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims 1
- 235000014113 dietary fatty acids Nutrition 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 229930195729 fatty acid Natural products 0.000 claims 1
- 239000000194 fatty acid Substances 0.000 claims 1
- 150000004665 fatty acids Chemical class 0.000 claims 1
- 229910052749 magnesium Inorganic materials 0.000 claims 1
- 239000011777 magnesium Substances 0.000 claims 1
- 239000002002 slurry Substances 0.000 claims 1
- 125000000969 xylosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)CO1)* 0.000 claims 1
- 239000008280 blood Substances 0.000 abstract description 15
- 210000004369 blood Anatomy 0.000 abstract description 15
- 239000000126 substance Substances 0.000 abstract description 9
- 230000001603 reducing effect Effects 0.000 abstract description 7
- 238000002360 preparation method Methods 0.000 abstract description 5
- 230000000694 effects Effects 0.000 abstract description 4
- 230000036772 blood pressure Effects 0.000 abstract description 3
- 238000000605 extraction Methods 0.000 abstract description 3
- BGMYHTUCJVZIRP-UHFFFAOYSA-N Nojirimycin Natural products OCC1NC(O)C(O)C(O)C1O BGMYHTUCJVZIRP-UHFFFAOYSA-N 0.000 abstract 1
- GAMYVSCDDLXAQW-AOIWZFSPSA-N Thermopsosid Natural products O(C)c1c(O)ccc(C=2Oc3c(c(O)cc(O[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O4)c3)C(=O)C=2)c1 GAMYVSCDDLXAQW-AOIWZFSPSA-N 0.000 abstract 1
- 230000009286 beneficial effect Effects 0.000 abstract 1
- 229930003944 flavone Natural products 0.000 abstract 1
- 150000002212 flavone derivatives Chemical class 0.000 abstract 1
- 235000011949 flavones Nutrition 0.000 abstract 1
- 235000003599 food sweetener Nutrition 0.000 abstract 1
- 150000002632 lipids Chemical class 0.000 abstract 1
- BGMYHTUCJVZIRP-GASJEMHNSA-N nojirimycin Chemical compound OC[C@H]1NC(O)[C@H](O)[C@@H](O)[C@@H]1O BGMYHTUCJVZIRP-GASJEMHNSA-N 0.000 abstract 1
- 239000003765 sweetening agent Substances 0.000 abstract 1
- VHBFFQKBGNRLFZ-UHFFFAOYSA-N vitamin p Natural products O1C2=CC=CC=C2C(=O)C=C1C1=CC=CC=C1 VHBFFQKBGNRLFZ-UHFFFAOYSA-N 0.000 abstract 1
- 241000256836 Apis Species 0.000 description 21
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Substances N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 7
- 206010012601 diabetes mellitus Diseases 0.000 description 6
- 230000002218 hypoglycaemic effect Effects 0.000 description 6
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical group [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 4
- 239000008103 glucose Substances 0.000 description 4
- 229940125396 insulin Drugs 0.000 description 4
- 210000000496 pancreas Anatomy 0.000 description 4
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 3
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 3
- 229930013930 alkaloid Natural products 0.000 description 3
- 150000003797 alkaloid derivatives Chemical class 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 3
- 229930003935 flavonoid Natural products 0.000 description 3
- 150000002215 flavonoids Chemical class 0.000 description 3
- 235000017173 flavonoids Nutrition 0.000 description 3
- 235000019359 magnesium stearate Nutrition 0.000 description 3
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 239000002808 molecular sieve Substances 0.000 description 3
- URGAHOPLAPQHLN-UHFFFAOYSA-N sodium aluminosilicate Chemical compound [Na+].[Al+3].[O-][Si]([O-])=O.[O-][Si]([O-])=O URGAHOPLAPQHLN-UHFFFAOYSA-N 0.000 description 3
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical group OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 3
- 229960002675 xylitol Drugs 0.000 description 3
- 235000010447 xylitol Nutrition 0.000 description 3
- 239000000811 xylitol Substances 0.000 description 3
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 description 2
- 235000017166 Bambusa arundinacea Nutrition 0.000 description 2
- 235000017491 Bambusa tulda Nutrition 0.000 description 2
- 241001330002 Bambuseae Species 0.000 description 2
- 235000015334 Phyllostachys viridis Nutrition 0.000 description 2
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 2
- 229960004373 acetylcholine Drugs 0.000 description 2
- 239000011425 bamboo Substances 0.000 description 2
- 229940038481 bee pollen Drugs 0.000 description 2
- 238000005520 cutting process Methods 0.000 description 2
- 125000002791 glucosyl group Chemical group C1([C@H](O)[C@@H](O)[C@H](O)[C@H](O1)CO)* 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- 230000006872 improvement Effects 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 239000012567 medical material Substances 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 238000000926 separation method Methods 0.000 description 2
- 238000000108 ultra-filtration Methods 0.000 description 2
- 238000002604 ultrasonography Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108010001394 Disaccharidases Proteins 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229920002527 Glycogen Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 208000004880 Polyuria Diseases 0.000 description 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000001014 amino acid Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 238000013459 approach Methods 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000000481 breast Anatomy 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 230000023852 carbohydrate metabolic process Effects 0.000 description 1
- 235000021256 carbohydrate metabolism Nutrition 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 230000003197 catalytic effect Effects 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 150000002016 disaccharides Chemical class 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 229940096919 glycogen Drugs 0.000 description 1
- 238000005469 granulation Methods 0.000 description 1
- 230000003179 granulation Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 230000002440 hepatic effect Effects 0.000 description 1
- 229940088597 hormone Drugs 0.000 description 1
- 239000005556 hormone Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 229940055726 pantothenic acid Drugs 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 239000011713 pantothenic acid Substances 0.000 description 1
- 230000002572 peristaltic effect Effects 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 206010036067 polydipsia Diseases 0.000 description 1
- 208000022530 polyphagia Diseases 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 239000000523 sample Substances 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
- A61K36/605—Morus (mulberry)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/896—Liliaceae (Lily family), e.g. daylily, plantain lily, Hyacinth or narcissus
- A61K36/8969—Polygonatum (Solomon's seal)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2013—Organic compounds, e.g. phospholipids, fats
- A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Insects & Arthropods (AREA)
- Zoology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Animal Husbandry (AREA)
- Nutrition Science (AREA)
- Physiology (AREA)
- Biophysics (AREA)
- Molecular Biology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Jellies, Jams, And Syrups (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明实施例公开了一种玉竹桑叶蜂王浆含片由下列重量份数的原料制成：天然蜂王浆50份～60份；玉竹水提取物的冻干粉20份～30份；桑叶水提取物的冻干粉10份～20份；甜味剂5份～10份；压片助流剂0.2份～0.6份。制备方法包括：准备天然蜂王浆冻干粉、玉竹水提取物的冻干粉和桑叶水提取物的冻干粉；混合原材料制备玉竹桑叶蜂王浆含片实施本发明实施例，具有如下有益效果：本发明在蜂王浆中添加了玉竹和桑叶，玉竹提取类黄酮物质与桑叶提取物脱氧野尻霉素结合形成一种新物质‑‑洗胰清糖素(cics)，具有降血糖、血脂、血压等作用。使得本发明一种玉竹桑叶蜂王浆含片与纯蜂王浆相比，降血糖功能大大加强。
Description
技术领域
本发明涉及一种保健食品及其生产方法，尤其涉及一种玉竹桑叶蜂王浆含片及生产方法。
背景技术
蜂王浆又名蜂皇浆、蜂乳，蜂王乳，蜂王浆的化学组成很复杂，蜂王浆不但含有高蛋白，并含有维生素B类和乙酰胆碱，脂肪、糖类、维生素A、维生素Bl、维生素B2、丰富的叶酸、泛酸及肌醇。还有类似乙酰胆碱样物质，而且还有多种人体需要的氨基酸和生物激素等。正因为成分复杂，所以蜂王浆的药理作用很强大。
蜂王浆含类胰岛素，能够辅助降低血糖，起到糖尿病辅助治疗的效果。但是单纯的蜂王浆对于血糖的降低效果有限，与此同时，传统的中医药中也包含了许多能够降低血糖的药材。选择合适的药材，采用现在先进的生产工艺，将其中的有效物质提取出来和蜂王浆结合在一起，对于提升蜂王浆降低血糖的功效具有重要意义。
发明内容
本发明实施例所要解决的技术问题在于，针对现在纯蜂王浆降血糖的效果不够理想的情况，提出了一种玉竹桑叶蜂王浆含片及生产方法。
为了解决上述技术问题，本发明实施例提供了一种玉竹桑叶蜂王浆含片及生产方法，该一种玉竹桑叶蜂王浆含片包括：天然蜂王浆50份～60份；玉竹水提取物的冻干粉20份～30份；桑叶水提取物的冻干粉10份～20份；甜味剂5份～10份；压片助流剂0.2份～0.6份。
其中，甜味剂为木糖醇。
其中，压片助流剂为硬脂酸镁。
一种玉竹桑叶蜂王浆含片的生产方法包括一下步骤：(1)以水提取法取得分子量小于5000D的玉竹水提取物的冻干粉，将玉竹粉碎并用纯净水浸泡，同时用低频超声波处理，然后采用冷冻离心法除去固体杂质，取上清液过5000D分子筛，取得分子量为5000D以下的玉竹粉水溶物，冷冻干燥制备玉竹水提取物的冻干粉；(2)按照步骤(1)的方法，用相同的方法取得分子量小于5000D的桑叶水提取物的冻干粉；(3)制备蜂王浆冻干粉；(4)制备玉竹桑叶蜂王浆含片，按照上述的质量分数比例称取天然蜂王浆、玉竹水提取物的冻干粉、桑叶水提取物的冻干粉、甜味剂以及压片助流剂，在沸腾锅中加入纯化水混合均匀加工，冷却干燥后进入压片机压片制得本发明一种玉竹桑叶蜂王浆含片。
其中，在步骤(1)中，离心转速为10000～12000转。
其中，蜂王浆冻干粉、玉竹水提取物的冻干粉以及桑叶水提取物的冻干粉的含水量均应小于5％。
其中，在步骤(4)中，在沸腾锅中混合原材料时1温度需要控制在18℃～23℃，湿度控制在40％～55％。
其中，在步骤(4)中，采用ZP1100压片机进行制片，工艺参数为：转速30～40转/分；工作压力7～15kN；片重0.4～0.6g。
实施本发明实施例，具有如下有益效果：本发明在蜂王浆中添加了玉竹和桑叶，玉竹提取类黄酮物质与桑叶提取物脱氧野尻霉素结合形成一种新物质--洗胰清糖素(cics)，具有降血糖、血脂、血压等作用。使得本发明一种玉竹桑叶蜂王浆含片与纯蜂王浆相比，降血糖功能大大加强。
附图说明
为了更清楚地说明本发明实施例或现有技术中的技术方案，下面将对实施例或现有技术描述中所需要使用的附图作简单地介绍，显而易见地，下面描述中的附图仅仅是本发明的一些实施例，对于本领域普通技术人员来讲，在不付出创造性劳动的前提下，还可以根据这些附图获得其他的附图。
图1是本发明提供的一种玉竹桑叶蜂王浆含片的生产方法的流程图。
具体实施方式
下面将结合本发明实施例中的附图，对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
请参见图1，图1是本发明提供的一种玉竹桑叶蜂王浆含片的生产方法的流程图。一种玉竹桑叶蜂王浆含片的生产步骤如下：
在步骤S1中，以水提取法取得分子量小于5000D的玉竹水提取物的冻干粉。
1.将玉竹清洗、除杂，并切割成小块待用。
2.将切割好的玉竹块在常温常压的条件下放置于纯净水中粉碎，然后以低频超声波处理10～40分钟，控制超声提取液的温度在10～40℃。
3.以10000～12000转冷冻离心法除去固体杂质，取上清液。
4.将上清液在1～5℃的环境温度下以5000D分子筛超滤分离，取得分子量为5000D以下的玉竹水溶性物质。
5.将上述玉竹水溶性物质冷冻干燥24～48小时制备含水量低于5％的蜂花粉水提物的冻干粉。
在步骤S2中，以水提取法取得分子量小于5000D的桑叶水提取物的冻干粉。
1.将桑叶清洗、除杂，并切割成小块待用。
2.将切割好的桑叶块在常温常压的条件下放置于纯净水中粉碎，然后以低频超声波处理10～40分钟，控制超声提取液的温度在10～40℃。
3.以10000～12000转冷冻离心法除去固体杂质，取上清液。
4.将上清液在1～5℃的环境温度下以5000D分子筛超滤分离，取得分子量为5000D以下的桑叶水溶性物质。
5.将上述桑叶水溶性物质冷冻干燥24～48小时制备含水量低于5％的蜂花粉水提物的冻干粉。
在步骤S3中，制备蜂王浆冻干粉。
将新鲜蜂王浆与冷冻干燥机中干燥36～48小时，制备含水量小于6％冻干粉。
在步骤S4中，混合原材料，制备玉竹桑叶蜂王浆含片。
1.按照如下的质量分数准备各个原材料：天然蜂王浆50份～60份；玉竹水提取物的冻干粉20份～30份；桑叶水提取物的冻干粉10份～20份；木糖醇5份～10份；硬脂酸镁0.2份～0.6份。
2.保持环境温度为18℃～23℃，湿度控制为40％～55％的情况下，将沸腾锅预热到40～60℃后，先将天然蜂王浆、玉竹水提取物的冻干粉、桑叶水提取物的冻干粉以及木糖醇加入沸腾锅内，打开蠕动泵喷纯化水进行一步制粒。制粒结束后加入硬脂酸镁混合均匀，低温冷却。
3.采用ZP1100压片机进行制片，工艺参数为：转速30～40转/分；工作压力7～15kN；片重0.4～0.6g。
木糖醇在体内新陈代谢不需要胰岛素参与，又不使血糖值升高，并可消除糖尿病人三多(多饮、多尿、多食)，因此是糖尿病人安全的甜味剂。
自古以来，中医就将桑叶作为治疗消渴症(即现代医学的糖尿病)的中药应用于临床，日本古书《吃茶养生记》也记载桑叶有改善“饮水病”(即现代医学的糖尿病)的作用。国内外研究资料证实，生物碱和多糖是桑叶中主要的降血糖成分。
桑叶的降血糖作用是通过两个途径实现的：一是通过生物碱DNJ(1-脱氧野尻霉素)对二糖类分解酶活性产生抑制作用，从而抑制小肠对双糖的吸收，降低食后血糖的高峰值；二是通过桑叶生物碱及桑叶多糖促进β细胞分必胰岛素，而胰岛素可以促进细胞对糖的利用、肝糖原合成以及改善糖代谢，最终达到降血糖的效果。
而玉竹提取类黄酮物质与桑叶提取物脱氧野尻霉素结合形成一种新物质--洗胰清糖素(cics)，进一步提高了降血糖的作用。
洗胰清糖素再和天然蜂王浆混合，蜂王浆中的多种生物酶成分起到了催化作用，进一步提高了降血糖的效果。
实施本发明实施例，具有如下有益效果：本发明在蜂王浆中添加了玉竹和桑叶，玉竹提取类黄酮物质与桑叶提取物脱氧野尻霉素结合形成一种新物质--洗胰清糖素(cics)，具有降血糖、血脂、血压等作用。使得本发明一种玉竹桑叶蜂王浆含片与纯蜂王浆相比，降血糖功能大大加强。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (8)
1.一种玉竹桑叶蜂王浆含片，其特征是由下列重量份数的原料制成：天然蜂王浆50份～60份；玉竹水提取物的冻干粉20份～30份；桑叶水提取物的冻干粉10份～20份；甜味剂5份～10份；压片助流剂0.2份～0.6份。
2.根据权利要求1所述的一种玉竹桑叶蜂王浆含片，其特征在于，所述甜味剂为木糖醇。
3.根据权利要求1所述的一种玉竹桑叶蜂王浆含片，其特征在于，所述压片助流剂为硬脂酸镁。
4.一种权利要求1所述的玉竹桑叶蜂王浆含片的生产方法，其特征包括一下步骤：
(1)以水提取法取得分子量小于5000D的玉竹水提取物的冻干粉，将玉竹粉碎并用纯净水浸泡，同时用低频超声波处理，然后采用冷冻离心法除去固体杂质，取上清液过5000D分子筛，取得分子量为5000D以下的玉竹粉水溶物，冷冻干燥制备玉竹水提取物的冻干粉；
(2)按照步骤(1)所述的方法，用相同的方法取得分子量小于5000D的桑叶水提取物的冻干粉；
(3)制备蜂王浆冻干粉；
(4)制备玉竹桑叶蜂王浆含片，按照上述的质量分数比例称取天然蜂王浆、玉竹水提取物的冻干粉、桑叶水提取物的冻干粉、甜味剂以及压片助流剂，在沸腾锅中加入纯化水混合均匀加工，冷却干燥后进入压片机压片制得本发明一种玉竹桑叶蜂王浆含片。
5.根据权利要求4所述的一种玉竹桑叶蜂王浆含片的生产方法，其特征在于，在所述步骤(1)中，离心转速为10000～12000转。
6.根据权利要求4所述的一种玉竹桑叶蜂王浆含片的生产方法，其特征在于，所述蜂王浆冻干粉、所述玉竹水提取物的冻干粉以及所述桑叶水提取物的冻干粉的含水量均应小于5％。
7.根据权利要求6所述的一种玉竹桑叶蜂王浆含片的生产方法，其特征在于，在所述步骤(4)中，在所述沸腾锅中混合原材料时1温度需要控制在18℃～23℃，湿度控制在40％～55％。
8.根据权利要求7所述的一种玉竹桑叶蜂王浆含片的生产方法，其特征在于，在所述步骤(4)中，采用ZP1100压片机进行制片，工艺参数为：转速30～40转/分；工作压力7～15kN；片重0.4～0.6g。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610747300.5A CN106387795A (zh) | 2016-08-26 | 2016-08-26 | 一种玉竹桑叶蜂王浆含片及生产方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610747300.5A CN106387795A (zh) | 2016-08-26 | 2016-08-26 | 一种玉竹桑叶蜂王浆含片及生产方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN106387795A true CN106387795A (zh) | 2017-02-15 |
Family
ID=58003521
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610747300.5A Pending CN106387795A (zh) | 2016-08-26 | 2016-08-26 | 一种玉竹桑叶蜂王浆含片及生产方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN106387795A (zh) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106923283A (zh) * | 2017-03-30 | 2017-07-07 | 南京老山药业股份有限公司 | 一种蜂王浆组合物及其制备方法 |
| CN114468108A (zh) * | 2020-11-11 | 2022-05-13 | 四川大学 | 一种紫金蜜桑叶含片及其制备方法 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1526433A (zh) * | 2003-09-25 | 2004-09-08 | 威海健方医药研究所 | 复方洋参剂及制备方法 |
| CN1528407A (zh) * | 2003-10-20 | 2004-09-15 | 中国农业科学院蜜蜂研究所 | 一种预防和治疗糖尿病的组合物 |
| CN102406836A (zh) * | 2011-11-11 | 2012-04-11 | 完美（中国）有限公司 | 一种具有辅助降血糖功能的中药组合物及其制备方法 |
-
2016
- 2016-08-26 CN CN201610747300.5A patent/CN106387795A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1526433A (zh) * | 2003-09-25 | 2004-09-08 | 威海健方医药研究所 | 复方洋参剂及制备方法 |
| CN1528407A (zh) * | 2003-10-20 | 2004-09-15 | 中国农业科学院蜜蜂研究所 | 一种预防和治疗糖尿病的组合物 |
| CN102406836A (zh) * | 2011-11-11 | 2012-04-11 | 完美（中国）有限公司 | 一种具有辅助降血糖功能的中药组合物及其制备方法 |
Non-Patent Citations (1)
| Title |
|---|
| 郭宏昌: "《中草药抗肿瘤便览》", 30 November 2014, 新疆人民卫生出版社 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106923283A (zh) * | 2017-03-30 | 2017-07-07 | 南京老山药业股份有限公司 | 一种蜂王浆组合物及其制备方法 |
| CN114468108A (zh) * | 2020-11-11 | 2022-05-13 | 四川大学 | 一种紫金蜜桑叶含片及其制备方法 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN1257724C (zh) | 一种预防和治疗糖尿病的组合物 | |
| CN107412721B (zh) | 一种降血糖苦瓜多肽复方胶囊及其制备方法 | |
| CN106578801A (zh) | 一种具有降糖作用的综合酵素粉及其制备方法 | |
| CN103039831A (zh) | 一种槐花保健米糕及其制备方法 | |
| CN113841894B (zh) | 黑果枸杞花青素提取物及冻干粉的制备方法和在抗氧化和抗衰老产品中的应用 | |
| CN105996028A (zh) | 生姜提取物、生姜纤维及其制备方法 | |
| CN112841617B (zh) | 一种利用鲜黑木耳制备的高收率、高活性黑木耳干粉及其制剂与制备方法 | |
| CN106387795A (zh) | 一种玉竹桑叶蜂王浆含片及生产方法 | |
| CN106261450A (zh) | 一种清热去火的红球藻泡腾片及其制备方法 | |
| CN105851764B (zh) | 一种青钱柳叶固体饮料及其制备方法和应用 | |
| CN109170734A (zh) | 复合蜂王浆制品及其制备方法 | |
| CN105031289A (zh) | 一种铁皮石斛灵芝胶囊及其制备方法 | |
| CN105685543A (zh) | 一种辅助治疗ii型糖尿病的功能片及其生产方法 | |
| CN107088206B (zh) | 一种桑白皮提取物的制备方法及其应用 | |
| CN101757059B (zh) | 从植物中提取α-葡萄糖苷酶活性抑制剂的方法 | |
| CN105343141A (zh) | 一种菱角壳提取物的咀嚼片的制备方法 | |
| CN107495202A (zh) | 一种原花色素保健食品及其制备方法 | |
| KR102469337B1 (ko) | 녹용 추출물 제조방법 및 녹용 추출물을 포함하는 녹용경옥고 | |
| CN101732370B (zh) | 从大叶补血草中提取α-葡萄糖苷酶活性抑制剂的方法 | |
| CN107411068A (zh) | 一种红枣环磷酸腺苷咀嚼片及其制备方法 | |
| CN106107402A (zh) | 一种清热解暑的红球藻泡腾片及其制备方法 | |
| CN106619972B (zh) | 蝙蝠蛾被毛孢菌丝体粉降血糖胶囊、其制备方法及用途 | |
| CN106420932B (zh) | 一种增加胰岛素敏感性的组合物及其应用 | |
| CN1895530A (zh) | 一种延缓衰老增强体质的保健品及其生产方法 | |
| CN110090243A (zh) | 一种用于餐后血糖控制的芡实提取物、制备方法及应用 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20170215 |
|
| RJ01 | Rejection of invention patent application after publication |